ZYNE ZYNE

Zynerba Pharmaceuticals Stock Price

1.34
0.04 (3.08%)
Upgrade to Real-Time
Afterhours (Closed)
1.34
Volume 490,348
Bid Price 1.28
Ask Price 1.34
News -
Day High 1.35

Low
0.8361

52 Week Range

High
4.6499

Day Low 1.26
Company Name Stock Ticker Symbol Market Type
Zynerba Pharmaceuticals Inc ZYNE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.04 3.08% 1.34 16:50:04
Open Price Low Price High Price Close Price Prev Close
1.34 1.26 1.35 1.31 1.30
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,896 490,348 $ 1.31 $ 643,645 - 0.8361 - 4.6499
Last Trade Time Type Quantity Stock Price Currency
19:57:38 1 $ 1.28 USD

Period:

Draw Mode:

Zynerba Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 60.12M 44.86M 42.95M $ - $ - -0.93 -1.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 424.66k 6.90%

more financials information »

Zynerba Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ZYNE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.191.391.171.25638,4720.1512.61%
1 Month1.141.391.091.20488,5680.2017.54%
3 Months1.011.600.891.19580,7570.3332.67%
6 Months2.652.830.83611.45448,024-1.31-49.43%
1 Year4.444.64990.83613.31957,154-3.10-69.82%
3 Years10.7512.510.83614.751,318,329-9.41-87.53%
5 Years5.8516.470.83616.231,146,555-4.51-77.09%

Zynerba Pharmaceuticals Description

Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system.


Your Recent History
NASDAQ
ZYNE
Zynerba Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now